Xuejin Ou

Xuejin Ou

Auto-generated profile, based on publicly available information

Xuejin Ou

Colorectal Cancer Center, West China Hospital, Sichuan University, Chengdu, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2019 in Contrast Media & Molecular Imaging
Verified
Journal Article
Open access
PDF file
YZYi Zhou
Yi Zhou
Xuelei MaXuelei Ma
Xuelei Ma
LPLu-Tong Pu
Lu-Tong Pu
RZRuo-Fan Zhou
Ruo-Fan Zhou
XOXue-Jin Ou
Xue-Jin Ou
RTRong Tian
Rong Tian
Purpose. To determine whether the radiomic features of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) contribute to prognosis prediction in primary gastric diffuse large B-cell lymphoma (PG-DLBCL) patients. Methods. This retrospective study included 35 PG-DLBCL patients who underwent PET/CT scans at West China Hospital before curative treatment. The volume of interest (VOI) was drawn around the tumor, and radiomic analysis of the PET and CT images, within the same VOI, was conducted. The metabolic and textural features of PET and CT images were evaluated. Correlations of the extracted features with the overall survival (OS) and progression-free survival (PFS) were evaluated. Univariate and multivariate analyses were conducted to assess the prognostic value of the radiomic parameters. Results. In the univariate model, many of the textural features, including kurtosis and volume, extracted from the PET and CT datasets were significantly associated with survival (5 for OS and 7 for PFS (PET); 7 for OS and 14 for PFS (CT)). Multivariate analysis identified kurtosis (hazard ratio (HR): 28.685, 95% confidence interval (CI): 2.067–398.152, p=0.012), metabolic tumor volume (MTV) (HR: 26.152, 95% CI: 2.089–327.392, p=0.011), and gray-level nonuniformity (GLNU) (HR: 14.642, 95% CI: 2.661–80.549, p=0.002) in PET and sphericity (HR: 11.390, 95% CI: 1.360–95.371, p=0.025) and kurtosis (HR: 11.791, 95% CI: 1.583–87.808, p=0.016), gray-level nonuniformity (GLNU) (HR: 6.934, 95% CI: 1.069–44.981, p=0.042), and high gray-level zone emphasis (HGZE) (HR: 9.805, 95% CI: 1.359–70.747, p=0.024) in CT as independent prognostic factors. Conclusion. 18F-FDG PET/CT radiomic features are potentially useful for survival prediction in PG-DLBCL patients. However, studies with larger cohorts are needed to confirm the clinical prognostication of these parameters.

26 September 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
HZHui Zhou
Hui Zhou
YLYuling Luo
Yuling Luo
Sha ZhuSha Zhu
Sha Zhu
XWXi Wang
Xi Wang
YZYunuo Zhao
Yunuo Zhao
Xuelei MaXuelei Ma
Xuelei Ma
Chimeric antigen receptor T (CAR T) cells immunotherapy is rapidly developed in treating cancers, especially relapsed or refractory B-cell malignancies. To assess the efficacy and safety of CAR T therapy, we analyzed clinical trials from PUBMED and EMBASE. Results showed that the pooled response rate, 6-months and 1-year progression-free survival (PFS) rate were 67%, 65.62% and 44.18%, respectively. We observed that received lymphodepletion (72% vs 44%, P = 0.0405) and high peak serum IL-2 level (85% vs 31%, P = 0.04) were positively associated with patients’ response to CAR T cells. Similarly, costimulatory domains (CD28 vs CD137) in second generation CAR T was positively associated with PFS (52.69% vs 33.39%, P = 0.0489). The pooled risks of all grade adverse effects (AEs) and grade ≥ 3 AEs were 71% and 43%. Most common grade ≥ 3 AEs were fatigue (18%), night sweats (14%), hypotension (12%), injection site reaction (12%), leukopenia (10%), anemia (9%). In conclusion, CAR T therapy has promising outcomes with tolerable AEs in relapsed or refractory B-cell malignancies. Further modifications of CAR structure and optimal therapy strategy in continued clinical trials are needed to obtain significant improvements.

31 January 2024 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Open access
PDF file
BZBo Zheng
Bo Zheng
PDPeiXin Du
PeiXin Du
ZZZhi Zeng
Zhi Zeng
PCPeng Cao
Peng Cao
Xuelei MaXuelei Ma
Xuelei Ma
YJYu Jiang
Yu Jiang
Purpose: This study will focus on 4T1 cells, a murine mammary adenocarcinoma cell line, as the primary research subject. We aim to investigate the inhibitory effects and mechanisms of propranolol on epithelial–mesenchymal transition (EMT) in breast cancer cells, aiming to elucidate this phenomenon at the miRNA level. Methods: In this study, the EMT inhibitory effect of propranolol was observed through in vitro and animal experiments. For the screening of potential target miRNAs and downstream target genes, second-generation sequencing (SGS) and bioinformatics analysis were conducted. Following the screening process, the identified target miRNAs and their respective target genes were confirmed using various experimental methods. To confirm the target miRNAs and target genes, Western Blot (WB), reverse transcription polymerase chain reaction (RT-PCR), and immunofluorescence experiments were performed. Results: In this study, we found that propranolol significantly reduced lung metastasis in 4T1 murine breast cancer cells (p < 0.05). In vitro and in vivo experiments demonstrated that propranolol inhibited the epithelial–mesenchymal transition (EMT) as evidenced by Western Blot analysis (p < 0.05). Through next-generation sequencing (SGS), subsequent bioinformatics analysis, and PCR validation, we identified a marked downregulation of miR-499-5p (p < 0.05), suggesting its potential involvement in mediating the suppressive effects of propranolol on EMT. Overexpression of miR-499-5p promoted EMT, migration, and invasion of 4T1 cells, and these effects were not reversed or attenuated by propranolol (Validated via Western Blot, wound healing assay, transwell migration, and invasion assays, p < 0.05). Sox6 was identified as a functional target of miR-499-5p, with its downregulation correlating with the observed EMT changes (p < 0.05). Silencing Sox6 or overexpressing miR-499-5p inhibited Sox6 expression, further promoting the processes of EMT, invasion, and migration in 4T1 cells. Notably, these effects were not alleviated by propranolol (validated via Western Blot, wound healing assay, transwell migration, and invasion assays, p < 0.05). The direct interaction between miR-499-5p and Sox6 mRNA was confirmed by dual-luciferase reporter gene assay. Conclusion: These results suggest that propranolol may have potential as a therapeutic agent for breast cancer treatment by targeting EMT and its regulatory mechanisms.

17 December 2019 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
YZYang Zhang
Yang Zhang
CCChaoyue Chen
Chaoyue Chen
YCYangfan Cheng
Yangfan Cheng
YTYuen Teng
Yuen Teng
WGWen Guo
Wen Guo
JXJianguo Xu
Jianguo Xu
Objectives: To investigate the ability of radiomics features from MRI in differentiating anaplastic oligodendroglioma (AO) from atypical low-grade oligodendroglioma using machine-learning algorithms. Methods: A total number of 101 qualified patients (50 participants with AO and 51 with atypical low-grade oligodendroglioma) were enrolled in this retrospective, single-center study. Forty radiomics features of tumor images derived from six matrices were extracted from contrast-enhanced T1-weighted (T1C) images and fluid-attenuation inversion recovery (FLAIR) images. Three selection methods were performed to select the optimal features for classifiers, including distance correlation, least absolute shrinkage and selection operator (LASSO), and gradient boosting decision tree (GBDT). Then three machine-learning classifiers were adopted to generate discriminative models, including linear discriminant analysis, support vector machine, and random forest (RF). Receiver operating characteristic analysis was conducted to evaluate the discriminative performance of each model. Results: Nine predictive models were established based on radiomics features from T1C images and FLAIR images. All of the classifiers represented feasible ability in differentiation, with AUC more than 0.840 when combined with suitable selection method. For models based on T1C images, the combination of LASSO and RF classifier represented the highest AUC of 0.904 in the validation group. For models based on FLAIR images, the combination of GBDT and RF classifier showed the highest AUC of 0.861 in the validation group. Conclusion: Radiomics-based machine-learning approach could potentially serve as a feasible method in distinguishing AO from atypical low-grade oligodendroglioma.

3 August 2020 in Contrast Media & Molecular Imaging
Verified
Journal Article
Open access
PDF file
BZBo Zheng
Bo Zheng
JWJiayi Wu
Jiayi Wu
ZZZixuan Zhao
Zixuan Zhao
XOXuejin Ou
Xuejin Ou
PCPeng Cao
Peng Cao
Xuelei MaXuelei Ma
Xuelei Ma
Background. The National Comprehensive Cancer Network guidelines recommend excisional biopsies for the diagnosis of lymphomas. However, resection biopsies in all patients who are suspected of having malignant lymph nodes may cause unnecessary injury and increase medical costs. We investigated the usefulness of 18F-fluorodeoxyglucose positron emission/computed tomography- (18F-FDG-PET/CT-) based radiomics analysis for differentiating between lymphomatous lymph nodes (LLNs) and cancerous lymph nodes (CLNs). Methods. Using texture analysis, radiomic parameters from the 18F-FDG-PET/CT images of 492 lymph nodes (373 lymphomatous lymph nodes and 119 cancerous lymph nodes) were extracted with the LIFEx package. Predictive models were generated from the six parameters with the largest area under the receiver operating characteristics curve (AUC) in PET or CT images in the training set (70% of the data), using binary logistic regression. These models were applied to the test set to calculate predictive variables, including the combination of PET and CT predictive variables (PREcombination). The AUC, sensitivity, specificity, and accuracy were used to compare the differentiating ability of the predictive variables. Results. Compared with the pathological diagnosis of the patient's primary tumor, the AUC, sensitivity, specificity, and accuracy of PREcombination in differentiating between LLNs and CLNs were 0.95, 91.67%, 94.29%, and 92.96%, respectively. Moreover, PREcombination could effectively distinguish LLNs caused by various lymphoma subtypes (Hodgkin's lymphoma and non-Hodgkin's lymphoma) from CLNs, with the AUC, sensitivity, specificity, and accuracy being 0.85 and 0.90, 77.78% and 77.14%, 97.22% and 88.89%, and 90.74% and 83.10%, respectively. Conclusions. Radiomics analysis of 18F-FDG-PET/CT images may provide a noninvasive, effective method to distinguish LLN and CLN and inform the choice between fine-needle aspiration and excision biopsy for sampling suspected lymphomatous lymph nodes.

17 September 2020 in Research Square
Verified
Preprint
Open access
PDF file
YYYuhan Yang
Yuhan Yang
BZBo Zheng
Bo Zheng
YWYixi Wang
Yixi Wang
XMXuelei Ma
Xuelei Ma
Objective: To construct a deep-learning convolution neural network (DL-CNN) system for pathological diagnosis of cervical lymph nodes by using computed tomography (CT), fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography (PET), and fused PET/CT images.Materials and methods: A total of 1020 cross-sectional images for each imaging modality was obtained from 211 patients (153 patients with lymphomas and 116 patients with metastases) with enlarged cervical lymph nodes from January 2014 to June 2018. All eligible images were distributed randomly into the training, validation, and testing cohorts with ratios of 70%, 15%, and 15%. We applied eight DL-CNN algorithms with pretrained bases from ImageNet dataset on CT, PET, and fused PET/CT imaging datasets to differentiate lymphomatous nodes from metastatic nodes, respectively. Attention heatmaps of PET and fused PET/CT images generated by class activation mapping (CAM) were used in visualization of class specific regions recognized by the prediction model with best performance. Results: The accuracy of eight deep learning algorithms with pretrained base ranged from 0.650 to 0.981 on PET testing cohort, and from 0.738 to 0.981 on fused PET/CT testing cohort. The VGG16 model on PET images and DenseNet121 model on fused PET/CT images had the best diagnostic performance among all eight algorithms with sensitivity and specificity of 1.000 and 0.963. Class-specific discriminative subregions were highlighted by attention maps for clinical review.Conclusion: A DL-CNN system was developed for classifying metastatic and lymphomatous involvement with favorable diagnostic performance on PET and PET/CT images in patients with enlarged cervical lymph nodes. The further clinical practice of this system may improve quality of the following therapeutic interventions and optimize patients’ outcomes.